Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LCNB
|
Matthew Palmer Layer
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 1,593 Added 14.27% |
-
|
Feb 19
2019 |
|
LCNB
|
Steve P Foster
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,097 Added 9.37% |
-
|
Feb 19
2019 |
|
NOG
|
Crestview Partners Iii Gp, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 240,373 Reduced 0.62% |
$610,547
$2.54 p/Share
|
Feb 19
2019 |
|
CBRI
|
Legion Partners Asset Management, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 160,000 Reduced 1.94% |
-
|
Feb 19
2019 |
|
AVLR
|
Warburg Pincus & Co.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,700,000 Reduced 33.67% |
$230,440,994
$49.03 p/Share
|
Feb 19
2019 |
|
BK
|
Hani A. Kablawi
Sr. Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,426 Reduced 2.97% |
$75,564
$52.99 p/Share
|
Feb 19
2019 |
|
TCRR
|
Mpm Bio Ventures 2014, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 706,666 Added 14.85% |
$10,599,990
$15.0 p/Share
|
Feb 19
2019 |
|
TCRR
|
Mpm Bio Ventures 2014, L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect | 3,148,297 Added 28.57% |
-
|
Feb 19
2019 |
|
TCRR
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 666,667 Added 16.51% |
$10,000,005
$15.0 p/Share
|
Feb 19
2019 |
|
TCRR
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
BUY
Conversion of derivative security
|
Direct | 2,704,315 Added 50.0% |
-
|
Feb 19
2019 |
|
NTRS
|
Aileen B Blake
EVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct | 2,339 Added 15.48% |
-
|
Feb 19
2019 |
|
NTRS
|
Aileen B Blake
EVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 560 Reduced 5.1% |
$51,985
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Biff Bowman
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,718 Reduced 4.29% |
$345,142
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Biff Bowman
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,694 Added 8.66% |
-
|
Feb 19
2019 |
|
NTRS
|
Robert P Browne
EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,623 Reduced 5.27% |
$336,323
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Robert P Browne
EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,562 Added 10.41% |
-
|
Feb 19
2019 |
|
NTRS
|
Peter Cherecwich
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,927 Reduced 14.79% |
$271,713
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Peter Cherecwich
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,748 Added 26.81% |
-
|
Feb 19
2019 |
|
NTRS
|
Steven L Fradkin
Vice Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 3,718 Reduced 9.14% |
$345,142
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Steven L Fradkin
Vice Chairman |
BUY
Grant, award, or other acquisition
|
Direct | 10,011 Added 17.57% |
-
|
Feb 19
2019 |
|
NTRS
|
Wilson Leech
EVP/Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 413 Reduced 1.08% |
$38,339
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Wilson Leech
EVP/Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,245 Added 13.88% |
-
|
Feb 19
2019 |
|
NTRS
|
Susan Cohen Levy
EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 3,014 Reduced 6.19% |
$279,790
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Susan Cohen Levy
EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 7,113 Added 11.87% |
-
|
Feb 19
2019 |
|
NTRS
|
Michael O'Grady
Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 3,718 Reduced 11.03% |
$345,142
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Michael O'Grady
Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 23,428 Added 30.49% |
-
|
Feb 19
2019 |
|
NTRS
|
Teresa Parker
President/Asset Servicing |
SELL
Payment of exercise price or tax liability
|
Direct | 2,485 Reduced 5.66% |
$230,683
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Teresa Parker
President/Asset Servicing |
BUY
Grant, award, or other acquisition
|
Direct | 14,920 Added 25.85% |
-
|
Feb 19
2019 |
|
NTRS
|
Thomas A South
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,259 Reduced 8.24% |
$116,873
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Thomas A South
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 3,388 Added 16.3% |
-
|
Feb 19
2019 |
|
NTRS
|
Clair Joyce St
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 4,431 Reduced 19.38% |
$411,330
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Clair Joyce St
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 7,509 Added 22.45% |
-
|
Feb 19
2019 |
|
NTRS
|
Shundrawn A Thomas
President / Asset Management |
SELL
Payment of exercise price or tax liability
|
Direct | 527 Reduced 1.85% |
$48,921
$92.83 p/Share
|
Feb 19
2019 |
|
NTRS
|
Shundrawn A Thomas
President / Asset Management |
BUY
Grant, award, or other acquisition
|
Direct | 7,113 Added 16.84% |
-
|
Feb 19
2019 |
|
ASB
|
Judith M Docter
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 1,960 Reduced 4.05% |
$45,550
$23.24 p/Share
|
Feb 19
2019 |
|
UVSP
|
Jeffrey M Schweitzer
Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 146 Reduced 0.28% |
$3,726
$25.52 p/Share
|
Feb 19
2019 |
|
CINF
|
Roger A Brown
Sr VP, COO - Subsidiary |
SELL
Payment of exercise price or tax liability
|
Direct | 350 Reduced 2.36% |
$29,883
$85.38 p/Share
|
Feb 19
2019 |
|
CINF
|
Roger A Brown
Sr VP, COO - Subsidiary |
BUY
Exercise of conversion of derivative security
|
Direct | 1,015 Added 6.4% |
-
|
Feb 19
2019 |
|
CINF
|
Sean Michael Givler
Exec Vice President - Sub |
SELL
Payment of exercise price or tax liability
|
Direct | 243 Reduced 4.19% |
$20,747
$85.38 p/Share
|
Feb 19
2019 |
|
CINF
|
Sean Michael Givler
Exec Vice President - Sub |
BUY
Exercise of conversion of derivative security
|
Direct | 700 Added 10.78% |
-
|
Feb 19
2019 |
|
CINF
|
Theresa A Hoffer
Sr Vice President - Subsidiary |
SELL
Payment of exercise price or tax liability
|
Direct | 1,202 Reduced 3.87% |
$102,627
$85.38 p/Share
|
Feb 19
2019 |
|
CINF
|
Theresa A Hoffer
Sr Vice President - Subsidiary |
BUY
Exercise of conversion of derivative security
|
Direct | 2,560 Added 7.85% |
$43,571
$17.02 p/Share
|
Feb 19
2019 |
|
CINF
|
Teresa C Cracas
EVP, Chief Risk Off. - Sub |
BUY
Exercise of conversion of derivative security
|
Indirect | 50 Added 3.36% |
-
|
Feb 19
2019 |
|
CINF
|
Teresa C Cracas
EVP, Chief Risk Off. - Sub |
SELL
Payment of exercise price or tax liability
|
Indirect | 17 Reduced 1.18% |
$1,451
$85.38 p/Share
|
Feb 19
2019 |
|
MKL
|
Steven A Markel
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.1% |
$101,485
$1014.85 p/Share
|
Feb 19
2019 |
|
MKL
|
Robert C Cox
Pres. & COO, Insur. Operations |
BUY
Grant, award, or other acquisition
|
Direct | 311 Added 21.4% |
$316,247
$1016.87 p/Share
|
Feb 19
2019 |
|
MKL
|
Nora N Crouch
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 108 Added 4.2% |
$109,822
$1016.87 p/Share
|
Feb 19
2019 |
|
MKL
|
Thomas Sinnickson Gayner
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,328 Added 3.52% |
$1,350,403
$1016.87 p/Share
|
Feb 19
2019 |
|
MKL
|
Richard Randolph Grinnan
SVP, Chief Legal Officer & Sec |
BUY
Grant, award, or other acquisition
|
Direct | 124 Added 7.78% |
$126,092
$1016.87 p/Share
|
Feb 19
2019 |
|
MKL
|
Michael R Heaton
EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 221 Added 14.02% |
$224,728
$1016.87 p/Share
|
Feb 19
2019 |